Prothrombotic and Antithrombotic Factors are Elevated in Patients with Type 1 Diabetes Complicated by Microalbuminuria
- 1 March 1993
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 10 (2) , 122-128
- https://doi.org/10.1111/j.1464-5491.1993.tb00028.x
Abstract
Increased urinary albumin loss in patients with Type 1 diabetes is associated with accelerated atherosclerosis. Prothrombotic factors known to be associated with cerebrovascular and coronary artery disease in the general population, and antithrombotic factors, were studied in 52 patients with Type 1 diabetes and varying urinary albumin loss and 24 non‐diabetic control subjects. Fibrinogen increased from 2.5 g I‐1 (95 % confidence interval 2.3–2.8) in control subjects and 2.8 g I‐1 (2.6–3.0) in diabetic patients without microalbuminuria to 3.1 g I‐1 (2.7–3.5) with microalbuminuria (p < 0.005 vs control; p < 0.001 vs without microalbuminuria). Factor VIIc increased from 81 % (75–86 % in non‐diabetic control subjects and 84 % (78–90 %) in diabetic patients without microalbuminuria to 103 % (89–117 %) with microalbuminuria (p < 0.005 vs control; p < 0.05 vs without microalbuminuria) and 118% (86–150%) with albuminuria (p < 0.005 vs control and p < 0.001 vs without microalbuminuria). Levels of the antithrombotic factors protein C, protein S, and antithrombin III also rose in the diabetic patients with evidence of renal damage. Elevation of prothrombotic factors has been associated with increased risk of microvascular disease, whereas elevation of antithrombotic factors has no known protective effect. Therefore, this pattern of alteration of haemostatic factors in diabetic renal disease may contribute to the increased risk of vascular disease associated with both microalbuminuria and albuminuria.Keywords
This publication has 34 references indexed in Scilit:
- Blood Rheology and Cardiovascular Risk Factors in Type 1 Diabetes: Relationship with MicroalbuminuriaDiabetic Medicine, 1991
- Fibrinolysis in patients with diabetic nephropathy determined by plasmin-α2 plasmin inhibitor complexes in plasmaJournal of Diabetic Complications, 1990
- Protein S and C antigen levels in proteinuric patients: Dependence on type of glomerular pathologyAmerican Journal of Hematology, 1989
- Increased plasma concentration of von Willebrand factor in insulin dependent diabetics with incipient nephropathy.BMJ, 1989
- Serum Lipids and Lipoproteins in Insulin‐dependent Diabetic Patients with Persistent MicroalbuminuriaDiabetic Medicine, 1989
- Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus.BMJ, 1987
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- Lipid Abnormalities in Insulin-dependent Diabetic Patients with AlbuminuriaDiabetes Care, 1984
- Hyperglycemia and Plasma Lipid LevelsNew England Journal of Medicine, 1980